JAK2 mutations are rare in de novo acute myeloid leukemia (AML), and JAK2-mutated acute myeloid leukemia (AML) patients usually have a previous history of myeloproliferative neoplasms (MPNs). Current advances in laboratory techniques, such as single nucleotide polymorphism array (SNPa) and next-generation sequencing (NGS), have facilitated new insight into the molecular basis of hematologic diseases. Herein, we present two cases of JAK2-mutated AML in which both SNPa and NGS methods added valuable information. Both cases had leukemogenic collaboration, namely, copy-neutral loss of heterozygosity (CN-LOH), detected on chromosome 9. One of the cases exhibited both JAK2 and IDH2 mutations, most likely having originated as an MPN with leukemic transformation, while the other case was classified as a de novo AML with JAK2, CEBPA, and FLT3 mutations.
Cytogenetics, Leukemia, Myeloid, Acute, Polymorphism, Single Nucleotide, Sequence Analysis, DNA
MesaRA, VerstovsekS, CervantesF, et al. Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). Leuk Res. 2007;31(6):737-40. [https://doi.org/10.1016/j.leukres.2006.12.002]. [PMID:17210175]
NoronhaT, Mitne-NetoM, ChauffailleM. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: The value of next-generation sequencing for genomic classification. J Investig Med. 2017;65(8):1155-8. [https://doi.org/10.1136/jim-2017-000566]. [PMID:28923882]
CortesJE, KantarjianH, O’BrienS, et al. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia. 1995;9(1):115-7. [PMID:7845005]
NoronhaTR, RohrS, ChauffailleM. Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes. Rev Bras Hematol Hemoter. 2015;37(1):48-54. [https://doi.org/10.1016/j.bjhh.2014.09.011]. [PMID:25638768]
NoronhaT, ChauffailleM. Multiple long runs of homozygosity detected by SNP array: offspring of consanguineous parents and his siblings. Adv Cytol Pathol. 2018;3(3):56-9.
GaymesTJ, MohamedaliA, EiliazadehAL, DarlingD, MuftiGJ. FLT3 and JAK2 mutations in acute myeloid leukemia promote interchromosomal homologous recombination and the potential for copy neutral loss of heterozygosity. Cancer Res. 2017;77(7):1697-708. [https://doi.org/10.1158/0008-5472.CAN-16-1678]. [PMID:28108507]
PassamontiF, RumiE, PietraD, et al. A prospective study of 338 patients with polycythemia vera: The impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia. 2010;24(9):1574-9. [https://doi.org/10.1038/leu.2010.148]. [PMID:20631743]
ImAP, SehgalAR, CarrollMP, et al. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia. 2014;28(9):1774-83. [https://doi.org/10.1038/leu.2014.124]. [PMID:24699305]
TefferiA, JimmaT, SulaiNH, et al. IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F. Leukemia. 2012;26(3):475-80. [https://doi.org/10.1038/leu.2011.253]. [PMID:21912393]